The ILC2 program supports organisations annually for projects to transform lung cancer patient care and improve the patient experience. Since 2020, selected projects have received a total near $2M. ILC2 projects span the globe across 17 countries, and target aspects of local areas and country-specific health systems. This year the program has added a couple of grants specific to small cell lung cancer.
The Lung Ambition Alliance invites patient organisations around the world to apply for this funding opportunity.